Introducing the AntiHuman Mu-type opioid receptor/OPRM1/μOR Antibody (BMS986122) – a powerful tool for studying opioid receptors and their role in pain management and addiction.
This highly specific antibody targets the Mu-type opioid receptor (OPRM1), a protein found in the central nervous system that plays a crucial role in mediating the effects of opioid drugs. It is a key player in the body’s response to pain, reward, and addiction.
The AntiHuman Mu-type opioid receptor antibody (BMS986122) is an ideal research target for scientists studying the mechanisms of opioid action, as well as those investigating potential treatments for pain and addiction. Its high affinity and selectivity for OPRM1 make it a valuable tool for understanding the complex interactions between opioids and their receptors.
This antibody has been extensively tested and validated in various experimental models, including in vitro and in vivo studies. Its specificity and sensitivity make it a reliable choice for a wide range of applications, including immunohistochemistry, immunofluorescence, and Western blotting.
In addition to its use in basic research, the AntiHuman Mu-type opioid receptor antibody (BMS986122) has potential applications in drug development. By targeting OPRM1, it can aid in the discovery and development of new pain medications with reduced side effects and decreased potential for abuse.
Don’t settle for generic explanations – choose the AntiHuman Mu-type opioid receptor antibody (BMS986122) for your next research project.
There are no reviews yet.